MétaCan
Menu
Back to cohort
Record W4387446403 · doi:10.1212/nxi.0000000000200167

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity

2023· article· en· W4387446403 on OpenAlexafffund
Gauruv Bose, Brian C. Healy, Shrishti Saxena, Fermisk Saleh, Bonnie I. Glanz, Rohit Bakshi, Howard L. Weiner, Tanuja Chitnis

Bibliographic record

VenueNeurology Neuroimmunology & Neuroinflammation · 2023
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsOttawa Hospital
FundersSanofi GenzymeEMD SeronoNational Institutes of HealthGenentechMultiple Sclerosis SocietyMultiple Sclerosis Society of CanadaMedDay PharmaceuticalsBiogenCelgeneCure Alzheimer's FundU.S. Department of DefenseSanofiVerily Life SciencesBristol-Myers Squibb
KeywordsGlial fibrillary acidic proteinMultiple sclerosisDiscontinuationNeurofilamentDiseaseMedicineChemistryPathologyInternal medicineImmunologyImmunohistochemistry

Abstract

fetched live from OpenAlex

<h3>Background and Objectives</h3> Stable patients with multiple sclerosis (MS) may discontinue treatment, but the risk of disease activity is unknown. Serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) are biomarkers of subclinical disease activity and may help risk stratification. In this study, sNfL and sGFAP levels in stable patients were evaluated before and after treatment discontinuation to determine association with disease activity. <h3>Methods</h3> This observational study included patients enrolled in the Comprehensive Longitudinal Investigation in MS at the Brigham and Women9s Hospital who discontinued treatment after &gt;2 years disease activity–free. Two serum samples within 2 years, before and after treatment stop, were sent for sNfL and sGFAP measurements by single-molecule array. Biannual neurologic examinations and yearly MRI scans determined disease activity by 3 time-to-event outcomes: 6-month confirmed disability worsening (CDW), clinical attacks, and MRI activity (new T2 or contrast-enhancing lesions). Associations between each outcome and log-transformed sNfL and sGFAP levels pretreatment stop and posttreatment stop and the percent change were estimated using multivariable Cox regression analysis adjusting for age, disability, disease duration, and duration from attack before treatment stop. <h3>Results</h3> Seventy-eight patients (92% female) discontinued treatment at a median (interquartile range) age of 48.5 years (39.0–55.7) and disease duration of 12.3 years (7.5–18.8) and were followed up for 6.3 years (4.2–8.5). CDW occurred in 27 patients (35%), new attacks in 19 (24%), and new MRI activity in 26 (33%). Higher posttreatment stop sNfL level was associated with CDW (adjusted hazard ratio (aHR) 2.80, 95% CI 1.36–5.76, <i>p</i> = 0.005) and new MRI activity (aHR 3.09, 95% CI 1.42–6.70, <i>p</i> = 0.004). Patients who had &gt;100% increase in sNfL level from pretreatment stop to posttreatment stop had greater risk of CDW (HR 3.87, 95% CI 1.4–10.7, <i>p</i> = 0.009) and developing new MRI activity (HR 4.02, 95% CI 1.51–10.7, <i>p</i> = 0.005). Patients who had &gt;50% increase in sGFAP level also had greater risk of CDW (HR 5.34, 95% CI 1.4–19.9, <i>p</i> = 0.012) and developing new MRI activity (HR 5.16, 95% CI 1.71–15.6, <i>p</i> = 0.004). <h3>Discussion</h3> Stable patients who discontinue treatment may be risk stratified by sNfL and sGFAP levels measured before and after discontinuing treatment. Further studies are needed to validate findings and determine whether resuming treatment in patients with increasing biomarker levels reduces risk of subsequent disease activity.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.810
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.270
Teacher spread0.224 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueNeurology Neuroimmunology & NeuroinflammationSame topicMultiple Sclerosis Research StudiesFrench-language works237,207